Sort by
Refine Your Search
-
interdisciplinary team and explore the complex relationship between behavior and brain health. This project focuses on developing novel measures of brain health by analyzing everyday behavioral patterns. What you
-
, synthetic chemists team up with immunologists from the Leiden University Medical Centre and computational scientists from the TU Delft to develop the next generation of synthetic CAAR cell therapy for serious
-
academic development are top priorities. Our people are committed to expand fundamental knowledge by curiosity and to look beyond the borders of their own discipline; their aim is to benefit science, and to
-
scientists from the TU Delft to develop the next generation of synthetic CAAR cell therapy for serious autoimmune conditions. The project is a shared position between the CBI-department (Leiden University) and
-
on the development of drugs modulating immunometabolism. Immune dysregulation contributes to many human diseases, including cancer, cardiovascular disease, chronic infections, and neurodegeneration. Developing drugs
-
on digital food systems and data governance. Co-develop and contribute to project podcasts and other public communication outputs. Help organize international workshops, conferences, and events with academic
-
Apply now PhD Candidate in Chemistry, Proteomics, and Immunology The Leiden Institute of Chemistry is looking for a PhD candidate to pursue research on the development of immune-modulatory drugs
-
PhD position understanding and designing nanomedicines-membranes interaction: physics based approach
the nanomedicines with high specificity to the desired target site in the body. In this PhD project, the candidate will experimentally study how to achieve high specificity by developing a quantitative understanding
-
is to deliver the nanomedicines with high specificity to the desired target site in the body. In this PhD project, the candidate will experimentally study how to achieve high specificity by developing
-
Institute of Chemistry are looking for a PhD candidate to pursue research on the development of host-directed therapeutics for mycobacterial infections. Mycobacterial infections are among the top 10 cause